Home » Teva Pursues First Type 1 Diabetes Treatment Since Insulin
Teva Pursues First Type 1 Diabetes Treatment Since Insulin
Teva Pharmaceutical, the world’s largest generic-drug maker, is seeking to transform a compound once rejected by Sanofi into the first treatment to succeed insulin for Type 1 diabetes.
Bloomberg
Bloomberg
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May